Skip to content

Member

Marta TEMIDO

S&D · Portugal

Group
S&D
Country
Portugal
Roll-call participation
89.8 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
99.3 %ⓘ of 557 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
PS Partido Socialista
In office
Since 16 Jul 2024
Against clear line
2 of 551 votesⓘ
Committees
AFET, AGRI (substitute), ENVI, SANT (substitute)
Member id
210480
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.8 %

557 of 620 final votes while in office

S&D median: 89.5 % (+0.3 pts)

Chamber median: 90.6 %

With majority line ⓘ

99.3 %

553 of 557 votes where their group had a line

S&D median: 97.1 % (+2.2 pts)

Against clear line ⓘ

0.4 %

2 of 551 votes where their group had a clear line

1 opposite (for ↔ against), 1 abstained against the line

Abstention ⓘ

0.5 %

3 of 557 votes cast

Participation 89.8 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Marta TEMIDO89.8 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 99.3 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Marta TEMIDO99.3 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
21 Jan 2026Request for opinion from the Court of Justice on the compatibility with the Treaties of the proposed EU-Mercosur Partnership Agreement (EMPA) and Interim Trade Agreement (ITA) Adopted 334 for, 324 against, 11 abstainedPosition: Against Majority line: Against
21 Jan 2026Implementation of the common foreign and security policy – annual report 2025 Adopted 392 for, 179 against, 83 abstainedPosition: For Majority line: For
21 Jan 2026Implementation of the common security and defence policy – annual report 2025 Adopted 395 for, 197 against, 70 abstainedPosition: For Majority line: For
21 Jan 2026Human rights and democracy in the world and the European Union’s policy on the matter – annual report 2025 Adopted 421 for, 120 against, 108 abstainedPosition: For Majority line: For
21 Jan 2026Addressing impunity through EU sanctions, including the EU Global Human Rights sanctions regime (so-called ‘EU Magnitsky Act’) Adopted 440 for, 127 against, 59 abstainedPosition: For Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Passed 503 for, 57 against, 108 abstainedPosition: For Majority line: For
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Adopted 492 for, 144 against, 28 abstainedPosition: For Majority line: For
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Adopted 420 for, 207 against, 20 abstainedPosition: For Majority line: For
20 Jan 2026Safeguarding and promoting financial stability amid economic uncertainties Adopted 491 for, 83 against, 84 abstainedPosition: For Majority line: For
20 Jan 2026Humanitarian aid in a time of polycrisis – reaffirming our principles for a more effective and ambitious response to humanitarian crises Adopted 444 for, 153 against, 55 abstainedPosition: For Majority line: For
20 Jan 2026Reform of the European Electoral Act – hurdles to ratification and implementation in the Member States Adopted 417 for, 234 against, 9 abstainedPosition: For Majority line: For
18 Dec 2025Arbitrary arrest and sentencing of academics Bahruz Samadov and Igbal Abilov in Azerbaijan Adopted 477 for, 7 against, 69 abstainedPosition: For Majority line: For
18 Dec 2025Mass kidnapping of children in Nigeria, including from St Mary’s Catholic School in Papiri Adopted 519 for, 2 against, 50 abstainedPosition: For Majority line: For
18 Dec 2025Grave political situation in Guinea-Bissau after the coup of 26 November Adopted 535 for, 0 against, 42 abstainedPosition: For Majority line: For
18 Dec 2025Implementation of the rule of law conditionality regime Adopted 386 for, 184 against, 15 abstainedPosition: For Majority line: For
18 Dec 2025Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear Adopted 450 for, 93 against, 37 abstainedPosition: For Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Adopted 438 for, 37 against, 48 abstainedPosition: For Majority line: For
17 Dec 2025Application of the ‘safe third country’ concept Negotiating mandate approved 384 for, 237 against, 31 abstainedPosition: Against Majority line: Against
17 Dec 2025Establishment of a list of safe countries of origin at Union level Negotiating mandate approved 396 for, 202 against, 56 abstainedPosition: Against Majority line: Against
17 Dec 2025Phasing out Russian natural gas imports, improving monitoring of potential energy dependencies Passed 500 for, 120 against, 32 abstainedPosition: For Majority line: For
17 Dec 2025Deforestation Regulation: certain obligations of operators and traders Passed 405 for, 242 against, 8 abstainedPosition: Against Majority line: Against
17 Dec 2025European High Performance Computing Joint Undertaking (EuroHPC) Passed 604 for, 37 against, 18 abstainedPosition: For Majority line: For
17 Dec 2025EU/Jordan Agreement for scientific and technological cooperation: terms and conditions for the participation of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 627 for, 13 against, 5 abstainedPosition: For Majority line: For
17 Dec 2025Simplification of the content and presentation of information to be disclosed concerning environmentally sustainable activities and simplification of certain technical screening criteria for determining whether economic activities cause no significant harm to environmental objectives Objection failed 230 for, 402 against, 28 abstainedPosition: For Majority line: For
17 Dec 2025Military Mobility Adopted 493 for, 127 against, 38 abstainedPosition: For Majority line: For
17 Dec 2025European Defence Readiness 2030: assessment of needs Adopted 425 for, 120 against, 96 abstainedPosition: For Majority line: For
17 Dec 2025Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work Adopted 480 for, 83 against, 94 abstainedPosition: For Majority line: For
17 Dec 2025European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ Adopted 358 for, 202 against, 79 abstainedPosition: For Majority line: For
16 Dec 2025Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 431 for, 161 against, 70 abstainedPosition: For Majority line: For
16 Dec 2025Amending the Directive on alternative dispute resolution for consumer disputes Amendment 1 rejected 122 for, 470 against, 69 abstainedPosition: Against Majority line: Against
16 Dec 2025Incentivising defence-related investments in the EU budget to implement the ReArm Europe Plan Passed 519 for, 119 against, 25 abstainedPosition: For Majority line: For
16 Dec 2025Amending certain CAP Regulations as regards the conditionality system, types of intervention in the form of direct payment, types of intervention in certain sectors and rural development and annual performance reports, data and interoperability governance, suspensions of payments annual performance clearance and controls and penalties Passed 629 for, 17 against, 16 abstainedPosition: For Majority line: For
16 Dec 2025Providing macro-financial assistance to Jordan Passed 585 for, 34 against, 45 abstainedPosition: For Majority line: For
16 Dec 2025Brexit Adjustment Reserve Passed 619 for, 6 against, 37 abstainedPosition: For Majority line: For
16 Dec 2025Corporate sustainability reporting and due diligence requirements Passed 428 for, 218 against, 17 abstainedPosition: Against Majority line: Against
16 Dec 2025Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/003 SE/Northvolt – Sweden Passed 578 for, 54 against, 30 abstainedPosition: For Majority line: For
16 Dec 2025Genetically modified maize NK603 Objection passed 479 for, 173 against, 8 abstainedPosition: For Majority line: For
16 Dec 2025Genetically modified sugar beet KWS20-1 Objection passed 455 for, 169 against, 8 abstainedPosition: For Majority line: For
16 Dec 2025Relations between the EU and Saudi Arabia Adopted 417 for, 131 against, 108 abstainedPosition: For Majority line: For
27 Nov 2025Amending Regulations on the Internal Market Information System (IMI) and on the single digital gateway as regards certain harmonisation requirements on transparency Passed 400 for, 77 against, 132 abstainedPosition: For Majority line: For
27 Nov 2025Harmonised requirements in the internal market on transparency of third countries interest representation Passed 392 for, 88 against, 133 abstainedPosition: For Majority line: For
27 Nov 2025Post-election killings and the deteriorating human rights situation in Tanzania, including the case of imprisoned opposition leader Tundu Lissu Adopted 539 for, 0 against, 27 abstainedPosition: For Majority line: For
27 Nov 2025Escalating repression of the Baha’is in Iran Adopted 549 for, 7 against, 31 abstainedPosition: For Majority line: For
27 Nov 2025Rule of law and human rights situation in Tunisia, particularly the case of Sonia Dahmani Adopted 464 for, 58 against, 75 abstainedPosition: For Majority line: For
27 Nov 2025Implementation of the EU-UK Trade and Cooperation Agreement Adopted 490 for, 41 against, 74 abstainedPosition: For Majority line: For
27 Nov 2025EU strategy for the rights of persons with disabilities post-2024 Adopted 490 for, 9 against, 109 abstainedPosition: For Majority line: For
27 Nov 2025Application of the Treaty provisions related to the principles of subsidiarity and proportionality and the role of national parliaments in the EU legislative process Adopted 337 for, 245 against, 12 abstainedPosition: Against Majority line: Against
27 Nov 2025Escalation of the war and the humanitarian catastrophe in Sudan Adopted 503 for, 32 against, 52 abstainedPosition: For Majority line: For
27 Nov 2025Political situation in Myanmar including the humanitarian crisis of the Rohingya Adopted 519 for, 3 against, 57 abstainedPosition: For Majority line: For
27 Nov 2025EU position on the proposed plan and EU engagement towards a just and lasting peace for Ukraine Adopted 401 for, 70 against, 90 abstainedPosition: For Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 9 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Iratxe GARCÍA PÉREZ S&DSpain98 % of 4 955 shared93 %
Isilda GOMES S&DPortugal98 % of 4 736 shared93 %
Carla TAVARES S&DPortugal98 % of 4 925 shared93 %
Sérgio GONÇALVES S&DPortugal98 % of 5 246 shared93 %
André FRANQUEIRA RODRIGUES S&DPortugal98 % of 4 676 shared93 %
Vilija BLINKEVIČIŪTĖ S&DLithuania98 % of 5 077 shared93 %
Camilla LAURETI S&DItaly98 % of 5 297 shared93 %
Francisco ASSIS S&DPortugal98 % of 4 287 shared93 %
Alicia HOMS GINEL S&DSpain98 % of 4 515 shared93 %
Ana Catarina MENDES S&DPortugal98 % of 4 852 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Yvan VEROUGSTRAETE RenewBelgium90 % of 3 912 shared86 %
Elisabetta GUALMINI changed group RenewItaly90 % of 1 672 shared86 %
Bernard GUETTA RenewFrance90 % of 5 043 shared86 %
Jana TOOM RenewEstonia90 % of 4 675 shared86 %
Dainius ŽALIMAS RenewLithuania90 % of 5 087 shared86 %
Gerben-Jan GERBRANDY RenewNetherlands90 % of 5 298 shared86 %
Ľudovít ÓDOR RenewSlovakia90 % of 5 051 shared86 %
Brigitte VAN DEN BERG RenewNetherlands90 % of 4 529 shared86 %
Marjan ŠAREC RenewSlovenia90 % of 5 149 shared86 %
Pascal CANFIN RenewFrance90 % of 4 801 shared86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Foreign AffairsAFET CommitteeMember19 Jul 2024now
Committee on Agriculture and Rural DevelopmentAGRI CommitteeSubstitute19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Subcommittee on Human RightsDROI SubcommitteeVice-chair23 Jul 2024now
Delegation for relations with IsraelD-IL DelegationMember19 Sept 2024now
Delegation to the OACPS-EU Joint Parliamentary AssemblyDACP Parliamentary assemblySubstitute19 Sept 2024now
Delegation to the Africa-EU Parliamentary AssemblyDAFR Parliamentary assemblySubstitute19 Sept 2024now
Delegation to the Parliamentary Assembly of the Union for the MediterraneanDMED Parliamentary assemblyMember19 Sept 2024now
Intergroup on Seas, Rivers, Islands and Coastal Areas (SEARICA)IG10-20 Intergroup / working groupMember4 Feb 2025now

Show all 14 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Recommendation to the Council, the Commission and the Vice-President of the Commission / High Representative of the Union for Foreign Affairs and Security Policy on EU engagement in the Horn of Africa – challenges and strategic prioritiesRapporteurAFET7 Sept 2026
Mission with the Delegation to the EU-Ukraine Parliamentary Association CommitteeOfficial delegation24 Jun 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsRapporteurENVI5 May 2026
Modernised rules for patients’ rights in cross-border healthcareShadow rapporteurSANT23 Apr 2026
Towards an EU strategy to protect and strengthen the international justice system and its institutions, mechanisms and partnersShadow rapporteurAFET21 Apr 2026
Psychosocial risks, stress and mental health at workShadow rapporteur for an opinionSANT8 Apr 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsRapporteurENVI16 Mar 2026
Establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034Opinion rapporteurENVI2 Feb 2026
The Commission’s 2025 Rule of Law report – annual report 2025Shadow rapporteur for an opinionAFET26 Jan 2026
Establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034Shadow rapporteur for an opinionENVI22 Jan 2026

Show all 26 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

80 contributions recorded, 1 written statement; 10 on behalf of their group; 105 minutes of speaking time.

Show all 40 recent contributions

Questions and motions, 41

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
16 Jul 2026Ensuring the continued operation of the Blue Flag Programme under Directive (EU) 2024/825 E-10-2026-003031Written questionwith 29 co-authors18 Sept 2026
16 Jul 2026Urgent appeal for the release of Dr Hussam Abu Safiya E-10-2026-003029Written questionwith 17 co-authors2 Sept 2026
15 Jul 2026Arbitrary preventive arrest of the leader of the opposition in Guinea-Bissau, Domingos Simões Pereira P-10-2026-002953Priority written questionwith 7 co-authors7 Aug 2026
15 Jul 2026Implementation of Case C-81/24 (Jenec) and protection against extraterritorial sanctions targeting international justice E-10-2026-002968Written questionwith 15 co-authors17 Sept 2026
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
19 Jun 2026Ban the butt: it is time to stub out cigarette filters E-10-2026-002547Written questionwith 9 co-authors3 Sept 2026
17 Jun 2026Request that the Commission publish evidence pertaining to the non-activation of the Blocking Statute E-10-2026-002520Written questionwith 31 co-authorsNot yet answered
9 Jun 2026Sovereignty of European payment system Wero P-10-2026-002371Priority written questionwith 9 co-authors18 Sept 2026
19 May 2026MOTION FOR A RESOLUTION on holding Israel to account for breaches of human rights and international law B-10-2026-0267Motion for a resolutionwith 55 co-authors—
21 Apr 2026Customs practices related to products imported from illegal Israeli settlements in the OPTs E-10-2026-001633Written questionwith 71 co-authors16 Jul 2026

Show all 41 questions and motions

Amendments tabled in committee, 102

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT21
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT4
4 Sept 2026Shaping the EU's external action to address the human rights challenges posed by artificial intelligence AFET-AM-792048 AFET50
4 Sept 2026Shaping the EU's external action to address the human rights challenges posed by artificial intelligence AFET-AM-792029 AFET17
16 Jul 2026General budget of the European Union for the financial year 2027 - all sections AFET-AM-791057 AFET12
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ5323
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ5312
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5326
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ5324

Show all 102 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Portugal National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 579b2832c723 (26 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
26 September 2026

Cite as

EU Parl Watch Research (2026). “Marta TEMIDO”. Member record. memberId 210480. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/210480?page=6&rows=all&scope=final (retrieved 26 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/210480. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/210480?format=application%2Fld%2Bjson (CC BY 4.0); data version 579b2832c723 (26 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-210480,
  author = {{EU Parl Watch Research}},
  title = {{Marta TEMIDO}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/210480?page=6&rows=all&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/210480?page=6&rows=all&scope=final},
  urldate = {2026-09-26},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 210480. Official source: https://www.europarl.europa.eu/meps/en/210480. Data: EP Open Data: member record (CC BY 4.0); data version 579b2832c723 (26 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}